Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Dechend

Showing results (191-200 of 254) with videos related to

Pageof 26
Sort By:
BMJ Open|January 9, 2025
Sex hormone-dependent host-microbiome interactions and cardiovascular risk (XCVD): design of a longitudinal multi-omics cohort studyKristina Franz, Lajos Markó, Anja Mähler, et al.
JAMA Cardiology|February 18, 2026
Clinical Factors and Biomarkers During Pregnancy and Risk of Cardiovascular DiseaseLucas Bacmeister, Dorte Glintborg, Jens-Jakob Kjer-Møller, et al.
Cytokine|July 3, 2016
Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)Irena Rohr, Elena I Braicu, Abdelaziz En-Nia, et al.
Hypertension (Dallas, Tex. : 1979)|May 11, 2011
Adipose tissue-derived soluble fms-like tyrosine kinase 1 is an obesity-relevant endogenous paracrine adipokineFlorian Herse, John N Fain, Juergen Janke, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 2019
Aldosterone, Salt, and Potassium Intakes as Predictors of Pregnancy Outcome, Including PreeclampsiaAnna Birukov, Louise Bjørkholt Andersen, Florian Herse, et al.
Circulation|June 9, 2005
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damageAnette Fiebeler, Jürg Nussberger, Erdenechimeg Shagdarsuren, et al.
Hypertension (Dallas, Tex. : 1979)|September 5, 2013
Amyloid-β peptides activate α1-adrenergic cardiovascular receptorsNadine Haase, Florian Herse, Bastian Spallek, et al.
Scientific Reports|August 22, 2020
Effects of empagliflozin and target-organ damage in a novel rodent model of heart failure induced by combined hypertension and diabetesKristin Kräker, Florian Herse, Michaela Golic, et al.
The American Journal of Pathology|November 5, 2002
Immunosuppressive treatment protects against angiotensin II-induced renal damageDominik N Muller, Erdenechimeg Shagdarsuren, Joon-Keun Park, et al.
Molecular Neurodegeneration|November 16, 2014
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's diseaseDe-Hyung Lee, Harald Heidecke, Alexandra Schröder, et al.
Pageof 26

Showing results (191-200 of 254) with videos related to

Sort By:
Pageof 26
BMJ Open|January 9, 2025
Sex hormone-dependent host-microbiome interactions and cardiovascular risk (XCVD): design of a longitudinal multi-omics cohort studyKristina Franz, Lajos Markó, Anja Mähler, et al.
JAMA Cardiology|February 18, 2026
Clinical Factors and Biomarkers During Pregnancy and Risk of Cardiovascular DiseaseLucas Bacmeister, Dorte Glintborg, Jens-Jakob Kjer-Møller, et al.
Cytokine|July 3, 2016
Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)Irena Rohr, Elena I Braicu, Abdelaziz En-Nia, et al.
Hypertension (Dallas, Tex. : 1979)|May 11, 2011
Adipose tissue-derived soluble fms-like tyrosine kinase 1 is an obesity-relevant endogenous paracrine adipokineFlorian Herse, John N Fain, Juergen Janke, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 2019
Aldosterone, Salt, and Potassium Intakes as Predictors of Pregnancy Outcome, Including PreeclampsiaAnna Birukov, Louise Bjørkholt Andersen, Florian Herse, et al.
Circulation|June 9, 2005
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damageAnette Fiebeler, Jürg Nussberger, Erdenechimeg Shagdarsuren, et al.
Hypertension (Dallas, Tex. : 1979)|September 5, 2013
Amyloid-β peptides activate α1-adrenergic cardiovascular receptorsNadine Haase, Florian Herse, Bastian Spallek, et al.
Scientific Reports|August 22, 2020
Effects of empagliflozin and target-organ damage in a novel rodent model of heart failure induced by combined hypertension and diabetesKristin Kräker, Florian Herse, Michaela Golic, et al.
The American Journal of Pathology|November 5, 2002
Immunosuppressive treatment protects against angiotensin II-induced renal damageDominik N Muller, Erdenechimeg Shagdarsuren, Joon-Keun Park, et al.
Molecular Neurodegeneration|November 16, 2014
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's diseaseDe-Hyung Lee, Harald Heidecke, Alexandra Schröder, et al.
Pageof 26